AGEX THERAPEUTICS INC (AGE)
Institutional ownership reported to the SEC as of Q2 2024, across 22 quarters.
1
Reporting holders
$405
Reported value
0.0%
Held as options
-33
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Strategic Investment Solutions, Inc. /IL | $405 | 250 | 0.00% | 5q | +66.7% |
Five percent filings
Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →
| Filed | Form | Filer | % of class |
|---|---|---|---|
| 2026-07-22 | 13D/A | Juvenescence Limitedwith 1 co-filers | 27.3% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2024 | 1 | $405 | 250 | 0 | 1 | 0 | 0.0% |
| Q4 2023 | 34 | $1.9M | 4,941,180 | 4 | 6 | 7 | 0.0% |
| Q3 2023 | 29 | $3.3M | 4,825,436 | 0 | 8 | 3 | 0.0% |
| Q2 2023 | 31 | $4.2M | 4,742,840 | 1 | 3 | 11 | 0.0% |
| Q1 2023 | 31 | $3.1M | 4,743,869 | 4 | 2 | 7 | 0.0% |
| Q4 2022 | 27 | $2.6M | 4,672,554 | 10 | 4 | 0 | 0.0% |
| Q3 2022 | 23 | $2.7M | 4,743,581 | 1 | 1 | 6 | 0.0% |
| Q2 2022 | 24 | $2.8M | 4,776,751 | 4 | 4 | 4 | 0.0% |
| Q1 2022 | 25 | $4.1M | 4,783,134 | 2 | 6 | 5 | 0.0% |
| Q4 2021 | 27 | $5.3M | 4,872,256 | 5 | 4 | 1 | 0.0% |
| Q3 2021 | 23 | $4.5M | 4,743,025 | 2 | 4 | 3 | 0.0% |
| Q2 2021 | 25 | $7.5M | 4,822,161 | 1 | 4 | 2 | 0.0% |
| Q1 2021 | 30 | $8.2M | 5,066,397 | 3 | 7 | 7 | 0.0% |
| Q4 2020 | 30 | $7.3M | 4,784,295 | 5 | 5 | 7 | 0.0% |
| Q3 2020 | 27 | $4.0M | 4,953,257 | 2 | 6 | 11 | 0.0% |
| Q2 2020 | 37 | $4.9M | 5,154,143 | 13 | 4 | 13 | 0.0% |
| Q1 2020 | 40 | $5.9M | 6,348,399 | 5 | 7 | 11 | 0.0% |
| Q4 2019 | 41 | $12.2M | 6,720,390 | 2 | 14 | 9 | 0.0% |
| Q3 2019 | 48 | $13.1M | 6,672,206 | 6 | 17 | 10 | 0.0% |
| Q2 2019 | 45 | $23.4M | 6,390,241 | 8 | 19 | 7 | 0.0% |
| Q1 2019 | 50 | $26.1M | 6,452,418 | 8 | 10 | 13 | 0.0% |
| Q4 2018 | 46 | $19.1M | 6,278,229 | 5 | 0 | 0 | 0.0% |